iguratimod: Clinical Trials

8 trials of iguratimod, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 1 not yet recruiting, 1 recruiting. 8 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Unknown 6, Not yet recruiting 1, Recruiting 1
Phase 12Recruiting 1, Unknown 1
Phase 31Unknown 1

Follow iguratimod: new trials by email Literature Review of iguratimod trials Research Report on iguratimod

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
Iguratimod, low-dose rituximab - Immune Thrombocytopenia (ITP)
Phase 2Not yet recruitingPeking University People's Hospital1202025-07-012025-07-10
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
Iguratimod - cGVHD
Phase 1 / Phase 2RecruitingXuzhou Medical University202024-01-102026-09-30
Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Iguratimod - Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1002022-03-222022-03-31
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
Iguratimod, placebo - Hand Osteoarthritis, Inflammatory Arthritis
Phase 2 / Phase 3UnknownPeking University People's Hospital1502022-03-012022-02-08
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Iguratimod, Danazol - ITP, Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1202021-09-012022-05-02
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
Iguratimod, Placebo - Primary Sjögren Syndrome
Phase 2UnknownJiangsu Simcere Pharmaceutical Co., Ltd.1442021-03-222021-07-19
The Iguratimod Effect on Lupus Nephritis (IGeLU)
Iguratimod, Cyclophosphamide, Azathioprine - Lupus Nephritis
Phase 2UnknownRenJi Hospital1202017-09-072018-12-19
Study of Iguratimod in Sjögren's Syndrome
Iguratimod - Sjogren's Syndrome
Phase 1 / Phase 2UnknownPeking Union Medical College Hospital302017-02-012017-01-18

Conditions studied

Purpura, Thrombocytopenic, Idiopathic (3)  ·  Arthritis (1)  ·  Lupus Nephritis (1)  ·  Nephritis (1)  ·  Sjogren's Syndrome (1)

Sponsors

Peking University People's Hospital (4)  ·  Jiangsu Simcere Pharmaceutical Co., Ltd. (1)  ·  Peking Union Medical College Hospital (1)  ·  RenJi Hospital (1)  ·  Xuzhou Medical University (1)

Countries

China (7)

Top investigators

Xiao-Hui Zhang, MD (2)  ·  Chunde Bao, MD (1)  ·  Xiaohui Zhang (1)  ·  Yan Zhao, Dr. (1)

Results publications

PMID 34380536